Biagio De Angelis

21PUBLICATIONS
103CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 25, 2026
HLA-Haploidentical Anti-CD7 Chimeric Antigen Receptor (CAR) T Cells for Transplant-Naïve Patients With Refractory T-Cell Acute Lymphoblastic Leukemia.

|Mar 03, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia.

Marco Becilli, Pietro Merli, Mattia Algeri

|Feb 05, 2026
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.

Marco Becilli, Markus Metzler, Claudia Bracaglia

|Nov 03, 2025
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcoma.

Francesca Antonella Aiello, Lucrezia D'Archivio, Marika Attili

|Sep 09, 2025
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.

Franco Locatelli, Daria Pagliara, Maria A De Ioris

|Aug 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.

Franco Locatelli, Daria Pagliara, Maria A De Ioris

Pageof 4

Frequent Collaborators

11 joint publications

Franco Locatelli

8 joint publications

Francesca Del Bufalo

7 joint publications

Pietro Merli

7 joint publications

Concetta Quintarelli